1. Olmesartan-induced Enteropathy Manifesting as Wernicke-Korsakoff Syndrome
- Author
-
Masatomi Ikusaka, Yusuke Hirota, Takanori Uehara, Akiko Ikegami, Hideki Kajiwara, Yoshiyuki Ohira, Takeshi Kondo, Shingo Suzuki, Kazutaka Noda, and Kiyoshi Shikino
- Subjects
Diarrhea ,Male ,medicine.medical_specialty ,Malabsorption ,malabsorption syndrome ,Tetrazoles ,Case Report ,Gastroenterology ,Diagnosis, Differential ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,urine anion gap ,intestinal pseudo-obstruction ,Internal Medicine ,medicine ,Humans ,Enteropathy ,Thiamine ,030212 general & internal medicine ,Severe diarrhea ,Aged ,Wernicke-Korsakoff syndrome ,Wernicke–Korsakoff syndrome ,business.industry ,digestive, oral, and skin physiology ,Imidazoles ,General Medicine ,medicine.disease ,Celiac Disease ,Korsakoff Syndrome ,Treatment Outcome ,Vitamin B Complex ,olmesartan-induced enteropathy ,Defecation ,030211 gastroenterology & hepatology ,Olmesartan ,business ,medicine.drug - Abstract
Cases of sprue-like enteropathy associated with olmesartan have sporadically been encountered since it was first reported in 2012, and their most characteristic manifestation is severe diarrhea. We herein report the first case of sprue-like enteropathy manifesting as Wernicke-Korsakoff syndrome due to vitamin B1 malabsorption with only minimally increased bowel movements. When patients are receiving olmesartan and they complain of nonspecific chronic gastrointestinal symptoms, it is important to consider changing the drugs before any serious malabsorption syndrome develops.
- Published
- 2016
- Full Text
- View/download PDF